A Phase 1/2, Open Label, Multicenter Trial to Assess the Safety and Efficacy of MB-102 in Patients with Relapsed or Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm
NOT ENROLLING
Trial ID:
NCT04109482 Protocol # :
19-544
Phase
I/II
Disease Sites
Other Hematopoietic
Myeloid and Monocytic Leukemia
Principal Investigator
Luskin, Marlise, R.
Site Research Nurses
Coleman, Kimberly, C.
Galinsky, Ilene
Kendricken, Elizabeth
Nguyen, Theresa, Tuyet Vy
O'Brien, Alexandra
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #19-544
19-544